Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

Completed · Phase 3

Conditions studied: Complication of Renal Dialysis, End Stage Renal Disease, End Stage Kidney Disease, ESRD, Chronic Kidney Failure, Complication of Hemodialysis, Vascular Access Complication, Arteriovenous Fistula

In brief

The objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).

Key facts

Study ID
NCT02513303
Run by
Vascular Therapies, Inc.
People needed
269
Starts
2015-11-01
Expected to finish
2021-06-01
Last updated by the study team
2025-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.